Endocrinology Medical News about GRAVES' ORBITOPATHY

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis
Journal of Clinical Endocrinology and Metabolism, 07/01/09

Salvi M et al. - GO may occur after RAI in approximately 15% of patients also in the absence of signs of active GO. Prophylactic OGC did not prevent GO activation in a large proportion of patients, compared to IVGC.

<< Previous
Adrenal function during childhood and puberty in daughters of...

Next >>
Mitochondrial Complex I Impairment in Leukocytes from Polycystic...

A Step Towards Individualized, Anatomy-Based Surgical Concepts for Orbital Decompression in Graves Orbitopathy
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09 Relevance Score: 67%

Imaging in Graves' Orbitopathy
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/10/09 Relevance Score: 67%

Thyroidectomy in Graves' Disease: Subtotal, Near Total or Total
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/09/09 Relevance Score: 67%

Graves' Disease Associated with Primary Systemic Sclerosis
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09 Relevance Score: 65%

A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves orbitopathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/02/09 Relevance Score: 65%